Cherwell, a specialist company in cleanroom microbiology solutions has published an update to its guide to ‘Environmental Monitoring Processes and Validation’, incorporating specific detail on the new version of EU GMP Annex 1. This aims to help sterile medicinal product manufacturers with reviewing and improving their environmental monitoring (EM) programs in preparation for compliance with the revised guidelines by August 2023.
Available to download from Cherwell’s website, the new eBook follows Cherwell’s EM experts’ detailed review of all changes included in the extensive 59-page 2022 revision of these key regulations governing the manufacture of sterile medicinal products in the UK and Europe. Cherwell’s updated guide adds new and more detail on a number of areas including: risk-based facility management; zero CFU; continuous EM; trends monitoring; personnel training; and VHP fumigation.
Cherwell’s EM eBook also includes an update to its section discussing how to achieve Annex 1 compliance in EM processes and programmes by taking a practical and bespoke approach to understanding the level of compliance required by individual facilities. This can be achieved by breaking down preparation into four steps, starting with a full EM audit and analysing every aspect of a facility’s current EM programme. To help further understanding, the guide also offers examples of best practice EM programmes within both industrial pharmaceutical and commercial scale hospitals and aseptic compounders.
“At Cherwell we strive to best support our customers in making the right decisions associated with combining methods and instruments to cost effectively achieve the best results for their individual EM and validation protocols,” said Thomas Parkhill, Microbiology Sales Specialist, Cherwell. “In this eBook, we offer a consultative guide to the most business-efficient EM measures organisations can adopt to comply with GMP Annex 1, and practical steps they can take to create the ideal EM process for their specific business needs.”
Hamish Hogg, Microbiology Product Specialist, Cherwell, added, “The sheer volume of new content in the much-revised GMP Annex 1 alone does present a challenge for businesses wanting to comply; they might be overwhelmed by the choices needed to determine the right path for them. That’s why we aim to work in an advisory role with our customers and assist them by drawing on the extensive knowledge and expertise held within our team. Our newly updated EM guide is just one such example.”
